Top 15% of pharmacy schools
The future of pharmacy starts here.
At the Skaggs School of Pharmacy, students from around the globe learn from award-winning faculty in a world-class medical setting. Hands-on training is dynamic, interprofessional and career-driven. From our entry-level PharmD program to flexible online degrees, our curriculum is innovative and agile, preparing students to be leaders in the emerging pharmacy careers of the future.
Explore Our Programs
PharmD Program
Interprofessional and experiential. From hospitals and industry settings, to clinics and pharmacies, our PharmD graduates are taking the lead optimizing medications and improving patient care.
Online Programs
We’ve been offering online degrees for more than 20 years. And it shows. Our online degrees and certificates deliver academic rigor in a flexible, interactive setting.
Master's Programs
Whether it’s a Master’s in Clinical Pharmacy, Pharmaceutical Sciences, or Palliative Care, adding an MS to your toolkit will deepen your patient-centered skills and increase your professional opportunities.
Top 10% in NIH funding
91% first-time NAPLEX pass rate
More than 1,300 rotation sites
95% of grads employed within 6 months
7 ACCP national award winners
Explore Our Campus
Learn on an Interprofessional Team
From the first week on campus, you’ll engage in experiential and interprofessional training that prepares you for team-based pharmacy careers.
Upcoming Events
Eight Things You Should Know About Omicron
Omicron cases are rising at staggering rates worldwide, and Colorado, once again, stands out as a national hotspot. CU experts Krishna Mallela, PhD and Ross Kedl, PhD try to answer questions as the world of COVID turns.
New Research Could Anticipate Covid’s Next Move
Dr. Krishna Mallela and his team, Dr. Vaibhav Upadhyay, PhD, and PhD student Alexandra Lucas, are working to identify new COVID-19 variants, before the virus can mutate itself.
P4’S Research Lands her National Fellowship and Faculty Admiration
P4 Madison Ricco combines her love of research with clinical practice, and won a Gateway to Research Award in the process.
Study highlights importance of positive and negative selection in evolution of SARS-CoV-2 variants
Krishna Mallela, PhD, and his team received press coverage for the lab’s work on SARS-CoV-2 variants, which focused on the study which highlights the importance of positive and negative selection in evolution of SARS-CoV-2 variants.
How the 2 New Pills for Treating COVID-19 Stack Up: Here's What Experts Say
Both Pfizer’s Paxlovid and Merck’s molnupiravir are cleared for emergency use in non-hospitalized people who have mild-to-moderate symptoms and are at heightened risk of developing severe disease. Peter Anderson, PharmD spoke with Health regarding their effectiveness.
Covid pills are ‘very promising’ – but what are the challenges in using them?
Peter Anderson, PharmD spoke with the Guardian about Paxlovid and molnupiravir, which were authorized by the FDA recently. Supplies of Paxlovid are limited while molnupiravir is less effective than hoped, but they are a very important step forward.
US, NGO combat cancer, train 34 Nigerian oncology pharmacists
Cindy O’Bryant, PharmD, had her recent Fulbright-sponsored work in Nigeria featured in a Vanguard article. The story examines the work being done to help reduce the high incidence of cancer, tackle late detection and improve general outlook of cancer in Nigeria.